Diagnostics Archives

News and Trends 13 Mar 2020

Immune Marker in Blood May Predict Kidney Transplant Rejection Risk

French researchers have found that the levels of certain immune cells in the blood of kidney transplant recipients may predict their future risk for transplant rejection. At present, kidney transplantation is the best treatment for people with end-stage renal disease but introducing a ‘foreign’ organ into someone’s body comes with the risk of rejection by […]

March 13, 2020 - 3 minutesmins - By Laura Cowen

Startup Scout 6 Mar 2020

This Startup Is Developing a DIY Biomarker Diagnostics Kit

The Swedish medical device startup Qlife is developing a diagnostic kit that patients can use at home to better control chronic diseases. Mission: To make convenient diagnostics for patients with a home-use kit that they can use to monitor blood biomarkers in chronic conditions such as arthritis. Chronic disorders such as cardiovascular disease and diabetes […]

March 6, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 4 Mar 2020

CN Bio Raises €8M to Boost Organ-on-a-Chip Rollout

UK cell culture specialist CN Bio Innovations has secured €7.98M (£7M) from Chinese investors to bolster its US market and expand European activities. Investment in the bioengineering company was led by Chinese investor CITIC Securities Company and with further support from existing Hong Kong-based investor CN Innovations Holdings. CN Bio, which creates benchtop instruments to […]

March 4, 2020 - 3 minutesmins - By External Contributor

antibiotic resistance southampton e coli

News and Trends 28 Feb 2020

Lasers Used To Make Rapid Antibiotic Resistance Test

Researchers from the University of Southampton in the UK have used laser technology to create a paper-based test that can identify bacteria in a urine sample and tell whether the species is showing antibiotic resistance. Urinary tract infections (UTIs) are the most commonly diagnosed infections worldwide and are typically caused by bacteria such as Escherichia […]

February 28, 2020 - 3 minutesmins - By Laura Cowen

News and Trends 18 Feb 2020

OncoDNA Secures €19M to Progress Precision Cancer Treatment Technology

Belgian biotech OncoDNA has raised €19M in Series B funding to further develop its cancer diagnostic and therapeutic decision-making software. The funding was led by Vesalius Biocapital, a Luxembourg-based VC investor, Swiss VC firm Swisscanto Invest by Zürcher Kantonalbank, and Belgian VC company SFPI-FPIM. Early investors in the company such as CPH Bank also contributed […]

February 18, 2020 - 2 minutesmins - By Helen Albert

stilla technologies pcr molecular diagnostics

News and Trends 11 Feb 2020

French Biotech Raises €20M to Make Precision Molecular Diagnostics

Stilla Technologies has raised a €20M Series C round to fund its mission to produce next-generation microchips that make molecular diagnostics more precise and user-friendly than currently available lab technology. Contributors to the round included Stilla’s existing investors, such as Illumina Ventures, Kurma Partners and Idinvest Partners. Stilla also added the Chinese company TUS-Holdings to […]

February 11, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 30 Jan 2020

Austrian Genomics Company Joins Fight Against Coronavirus

Ares Genetics will use next-generation sequencing technology from the Chinese genomics company BGI Group to track and control the spread of a new coronavirus originating in China. A new strain of coronavirus, dubbed 2019-nCoV and originating in the Chinese city of Wuhan, has caused widespread concern in recent weeks. While only 20% of people with […]

January 30, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 24 Jan 2020

€6M Seed Round to Develop First Urine Test for Kidney Cancer

The Swedish biotech Elypta has raised a seed round worth €6.1M to fund a clinical trial of a urine test for signs of recurrent kidney cancer, which could improve patient follow-up after surgery. The seed round was led by the Swedish VC firm Industrifonden. Other investors in the round included the VC impact fund of […]

January 24, 2020 - 3 minutesmins - By Jonathan Smith

centogene rare diseases diagnostic ipo nasdaq

News and Trends 7 Nov 2019

€51M Nasdaq IPO Will Fund Centogene’s Rare Disease Diagnostics

The German company Centogene has raised €50.6M ($56M) in an IPO on the Nasdaq Stock Exchange to fund the development of diagnostics technology that could improve the treatment of rare diseases. The fundraise fell under Centogene’s target value of €54M ($60M). A part of the proceeds will fuel the development of biomarkers that Centogene will […]

November 7, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 31 Oct 2019

European Project Launches to Tailor Autoimmune Disease Treatments

Public and private organizations across Europe will pool their resources in an €80M project to discover biomarkers that can predict which patients will respond best to treatments for autoimmune diseases. The project is called Taxonomy, Treatments, Targets and Remission, or 3TR for short, and is funded by the EU’s Innovative Medicines Initiative for the next […]

October 31, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 28 Oct 2019

AI-Driven Antibiotic Susceptibility Test Launched in Austria

Ares Genetics, an Austrian subsidiary of the German Curetis Group, has launched an early access program for its AI-driven antibiotic susceptibility test. The company, which focuses on molecular diagnostics, has a large, regularly updated database of genetic information on disease-causing microbes including strains showing antimicrobial resistance. The new test uses high-resolution sequencing to gain genetic […]

October 28, 2019 - 2 minutesmins - By Helen Albert

breathomix breath diagnostics lung cancer

News and Trends 19 Sep 2019

Dutch ‘Electronic Nose’ Predicts Cancer Immunotherapy Success

A diagnostic device measuring chemicals in the breath, developed by the Dutch company Breathomix, was able to identify lung cancer patients that wouldn’t respond to cancer immunotherapy with unprecedented accuracy. Researchers at the University of Amsterdam tested the device on 143 lung cancer patients, who were going to receive immunotherapy in the form of the […]

September 19, 2019 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Diagnostics

Immune Marker in Blood May Predict Kidney Transplant Rejection Risk

This Startup Is Developing a DIY Biomarker Diagnostics Kit

CN Bio Raises €8M to Boost Organ-on-a-Chip Rollout

Lasers Used To Make Rapid Antibiotic Resistance Test

OncoDNA Secures €19M to Progress Precision Cancer Treatment Technology

French Biotech Raises €20M to Make Precision Molecular Diagnostics

Austrian Genomics Company Joins Fight Against Coronavirus

€6M Seed Round to Develop First Urine Test for Kidney Cancer

€51M Nasdaq IPO Will Fund Centogene’s Rare Disease Diagnostics

European Project Launches to Tailor Autoimmune Disease Treatments

AI-Driven Antibiotic Susceptibility Test Launched in Austria

Dutch ‘Electronic Nose’ Predicts Cancer Immunotherapy Success

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!